Suscribirse

Mechanism of Gastrodin against neurotoxicity based on network pharmacology, molecular docking and experimental verification - 08/11/24

Doi : 10.1016/j.biopha.2024.117611 
Han Guo a, b, Chenyang Li a, Jiaojiao Zhao a, Tianyuan Guo c, Siruan Chen a, Xia Qin a, Kangsheng Zhu a, Wei Zhang a,
a Department of Pharmacology of Chinese Materia Medica, Institution of Chinese Integrative Medicine, Hebei Medical University, Shijiazhuang, Hebei Province, 050017, China 
b Department of Oral Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, 050000, China 
c Department of plastic surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, 050000, China 

Corresponding author.

Abstract

Background

Disorders of glutamate metabolism and excessive release participat in multiple neuronal pathologies including ischemic stroke (IS), Alzheimer's disease (AD), or Parkinson's disease (PD). Recently, herbal medicines have been widely used and have shown satisfactory results in the treatment of neurological disorders. Gastrodin is a traditional Chinese medicine (TCM) used for the treatment of nerve injuries, spinal cord injuries, and some central nervous system diseases as well. This research examines the neuroprotective effects of Gastrodin against glutamate-induced neurotoxicity in neuronal cells.

Methods

The HERB database was used to explore the active ingredients and target genes of Gastrodia Elata. The STRING database and Cytoscape software were used to screen and construct the Protein-Protein Interaction (PPI). Furthermore, we used molecular docking to predict the potential targets of Gastrodin. The effects of Gastrodin were revealed by western blot, calcium imaging, membrane clamp, CCK8 and flow cytometry. Neuronal oxidative stress and damage were assessed by measuring malondialdehyde (MDA) levels and superoxide dismutase (SOD) activity. Neuronal morphology was examined using Golgi-Cox staining. Finally, animal behavior was examined using novel object recognition and fear conditioning tests.

Results

We have obtained 22 components such as TM10, TM17, TM25 (Gastrodin), and 281 targets such as AKT, EGFR, and CDK1 through network pharmacology. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses revealed these genes were significantly enriched in protein phosphorylation, protein serine/threonine/tyrosine kinase activity, apoptosis and HIF-1 signaling pathways, etc. A higher affinity between Gastrodin and AKT was revealed by PPI analysis and molecular docking. Further, Gastrodin significantly inhibited Ca2+ influxes and excitatory synaptic transmission in cortical neurons. In addition, Gastrodin effectively alleviated neuron apoptosis, oxidative stress and damage.

Conclusion

Gastrodin has neuroprotective effects against glutamate-induced neurotoxicity.

El texto completo de este artículo está disponible en PDF.

Graphical Abstract




 : 

Gastrodin, a natural active compound derived from Gastrodia Elata, attenuates glutamate-induced neurotoxicity by inhibiting Ca2+ influx and excitatory synaptic transmission, thereby exerting neuroprotective effects.


Gastrodin, a natural active compound derived from Gastrodia Elata, attenuates glutamate-induced neurotoxicity by inhibiting Ca2+ influx and excitatory synaptic transmission, thereby exerting neuroprotective effects.

El texto completo de este artículo está disponible en PDF.

Highlights

Gastrodin, with notably high AKT affinity, was screened by network pharmacology.
Gastrodin inhibits glutamate-induced neuronal calcium overload and neurotoxicity.
Gastrodin provides neuroprotection by reducing neuronal oxidative stress and apoptosis.
Gastrodin promotes neuronal development by reducing synaptic damage and spine loss.

El texto completo de este artículo está disponible en PDF.

Abbreviations : AD, AUC, ANOVA, AP, [Ca2+]i, CDM, CFC, CNS, DMEM/F12, Glu, GO, IGluRs, IC50, IS, KEGG, Log FC, LTM, MDA, MEPSC, MF, MS, NMDA, NIH, OFT, ORT, PBS, PDL, PFC, PD, POCD, PPI, SOD, STM, TCM

Keywords : Glutamate, Gastrodin, Network pharmacology, Neurotoxicity, Oxidative stress


Esquema


© 2025  The Authors. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 180

Artículo 117611- novembre 2024 Regresar al número
Artículo precedente Artículo precedente
  • Cereblon mediates macrophage differentiation and microglial phagocytosis by regulating calpain protease activity
  • Liang Zhou, Qing Sun, Dan Cao
| Artículo siguiente Artículo siguiente
  • Fully human monoclonal antibody targeting the cysteine-rich substrate-interacting region of ADAM17 on cancer cells
  • Nayanendu Saha, Sang Gyu Lee, Eeva-Christine Brockmann, M. Jason de la Cruz, Yehuda Goldgur, Rachelle P. Mendoza, Elisa de Stanchina, Tanzy M. Love, Josh Marvald, Yan Xu, Kai Xu, Juha P. Himanen, Urpo Lamminmäki, Darren Veach, Dimitar B. Nikolov

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.